The Global Brain Cancer Diagnostic Market is expected to grow with a CAGR of 23.7% from 2024 to 2030

According to a market report by Lucintel, the future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 from $2.3 billion in 2024 at a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, increasing awareness of the early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.

A more than 150 – page report is developed to understand trends, opportunity and forecast in brain cancer diagnostic marketto 2030 by test type (imaging test, biopsy, lumber puncture, molecular testing, electroencephalography, and others), cancer type (acoustic neuroma, astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others), age group (children, adult, and geriatic), end use (hospitals, specialty clinics, diagnostic centers & research institutes, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that glioblastoma multiforme will remain the largest segment due to the etiological trends of lifestyle, genetic factors, and imprived diagnostic systems.

Within this market, hospitals is expected to witness highest growth over the forecast period due to increasing prevelance of brain cancer, hospital infrastructure, and increasing investments and funding in cancer daignostics.

Download sample by clicking on brain cancer diagnostic market

North America will remain the largest segment due to increasing research and development activities and improved imaging techniques.

Thermo Fisher Scientific, Siemens Healthcare Diagnostics, Hologic, Nantomics, GE Healthcare, Nihon Kohden, Canon, and Fujifilm Holdings are the major suppliers in the brain cancer diagnostic market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cast visit Lucintel’s Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1 972.636.5056

Explore Our Latest Publications

Communication Relay Drone Market

Electric Spraying Drone Market

Energy Storage for Drone Market

First Person View Drone Market

Frac Valve Market

Ballistic Composite Market

Filled Thermoplastic in European Consumer Goods Market

India Aerospace and Defense Market

CFT Market

Global Flame Retardant Resin in the Transportation Market

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Comments on “The Global Brain Cancer Diagnostic Market is expected to grow with a CAGR of 23.7% from 2024 to 2030”

Leave a Reply

Gravatar